Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Annual Meeting Talks

Sign in to view content

Sign in

Efficacy and Durability of Brolucizumab in Patients Being Transitioned From Prior Anti-VEGF Therapy

  • Scott D Walter, MD, MSc, FASRS
  • Video
  • Published 2021

Related

  • Long-term Anti-VEGF Treatment Following Vitrectomy for Endophthalmitis in Patients With Neovascular AMD

    Zofia Anna Nawrocka (vel Michalewska), MD, PhD

    Annual Meeting Talks

    2018

  • Outcomes in Proliferative Diabetic Retinopathy Patients Lost to Follow-up After Panretinal Photocoagulation Versus Antivascular

    Daniel Su, MD

    Updates from the Field

    2018

  • Phase IIIb TALON study of brolucizumab versus aflibercept in a matched treat-and-extend regimen to treat neovascular AMD: 32-week primary outcomes

    Carl D. Regillo, MD

    Annual Meeting Talks

    2022

Category: AMD-Neovascular

  • Anti-VEGF
  • brolucizumab
  • Wet AMD (neovascular)
  • comparative efficacy
  • intraocular inflammation

See more

  • Annual Meeting Talks
  • Scott D Walter, MD, MSc, FASRS
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists20 North Wacker Drive, Suite 2030,Chicago, Illinois 60606(312) 578-8760 phoneinfo@asrs.org
© 2025 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.